• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Endocrine . Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19

tetano

Editor, Senior Moderator
Endocrine


. 2022 Nov 9.
doi: 10.1007/s12020-022-03239-w. Online ahead of print.
Hypocalcemia is associated with adverse outcomes in patients hospitalized with COVID-19


Alessandro Minasi[SUP] 1 2 [/SUP], Aikaterini Andreadi[SUP] 1 2 [/SUP], Alessio Maiorino[SUP] 1 2 [/SUP], Luca Giudice[SUP] 1 2 [/SUP], Sofia De Taddeo[SUP] 1 2 [/SUP], Ilenia D'Ippolito[SUP] 1 2 [/SUP], Ilaria de Guido[SUP] 3 4 [/SUP], Rossella Laitano[SUP] 3 4 [/SUP], Maria Romano[SUP] 1 2 [/SUP], Valeria Ruotolo[SUP] 1 2 [/SUP], Andrea Magrini[SUP] 5 [/SUP], Nicola Di Daniele[SUP] 1 [/SUP], Paola Rogliani[SUP] 3 4 [/SUP], Alfonso Bellia[SUP] 1 2 [/SUP], Davide Lauro[SUP] 6 7 [/SUP]



Affiliations

Abstract

Purpose: Calcium ions are involved in the regulation of several cellular processes and may also influence viral replication. Hypocalcemia has been frequently reported during infectious diseases and in critically ill patients, including also COVID-19 patients, significantly related with the pro-inflammatory state and mortality. The aim of this study is to investigate the prevalence of hypocalcemia at admission in patients hospitalized for COVID-19 (Coronavirus disease 2019) and to evaluate association of hypocalcemia with in-hospital COVID-19 outcomes.
Methods: Retrospective analysis on 118 consecutive patients, hospitalized for COVID-19 between March and May 2020. Clinical characteristics, inflammation markers, biochemical routine and mineral metabolism parameters at admission were collected. Hypocalcemia was defined as total serum calcium <2.2 mmol/L. Population was stratified by tertiles of total serum calcium. Primary outcome was the composite of in-hospital death or admission to intensive care unit (ICU). Secondary outcomes included in-hospital death, admission to ICU and need for non-invasive ventilation as separate events. Associations were tested by logistic regression and Cox-regression analysis with survival curves.
Results: Overall prevalence of hypocalcemia was 76.6%, with just 6.7% of patients reporting levels of 25-(OH)-vitamin D > 30 ng/ml. Total serum calcium was inversely related with selected inflammatory biomarkers (p < 0.05) and poorer outcome of COVID-19 during hospitalization. Lower tertile of total calcium (≤2.02 mmol/L) had increased risk of in-hospital mortality (HR 2.77; 1.28-6.03, p = 0.01) compared with other groups.
Conclusion: Total serum calcium detected on admission is inversely related with proinflammatory biomarkers of severe COVID-19 and is useful to better define risk stratification for adverse in-hospital outcome.

Keywords: COVID-19; Hypocalcemia; Total serum calcium; Vitamin D.
 
Back
Top Bottom